ALT (A) The fingers of a 63-year-old woman with Parkinson disease showed flexion of the metacarpophalangeal and distal interphalangeal joints, extension of the proximal interphalangeal joints, and abduction of the little finger. Radiographs in (B) frontal and (C) oblique positions revealed no obvious bone erosions or joint space narrowing of the fingers.
ALT Oropouche virus infections are usually mild with self-limiting symptoms of fever, chills, headache and myalgias, similar to dengue, chikungunya and Zika.
ALT Future research on resource allocation during pandemics could shed light on potential inequities for vulnerable populations and how best to address them.
ALT Text: New articles on oropouche virus, finger deformities in Parkinson disease, non-celiac gluten sensitivities, and more in Volume 197, Issue 9 of the CMAJ. Image: Illustration of virus, arrow and mosquito
ALT As a composer, I have channelled emotions into art for as long as I can remember.
ALT (A) Red plaque on the right side of the face of a 58-year-old man with lupus vulgaris. (B) The plaque showed improvement after 8 months of antituberculosis treatment.
ALT Hallucinogens are a group of substances that influence perception and mood and are broadly classified into dissociative drugs, including phencyclidine (PCP) and ketamine, and serotonergic hallucinogens (psychedelics), including psilocybin, lysergic acid diethylamide (LSD), dimethyltryptamine (DMT, or ayahuasca), and methylenedioxymethamphetamine (MDMA, or Ecstasy).
ALT Text: New articles on hallucinogens and mortality, vitiligo, lupus vulgaris, and more in Volume 197, Issue 8 of the CMAJ. Image: Eye with colorful iris with glitch and noise effects applied to the image
ALT Erythematous–violaceous papules and plaques and petechiae on the (A) neck and (B) periflexural area of the axilla of an 18-year-old woman with parvovirus B19 infection.
ALT Bispecific antibodies are novel therapeutic agents that engage the immune system to eradicate cancer.
ALT In patients with type 2 diabetes and chronic kidney disease who had newly started SGLT2 inhibitor treatment showed a reduced incidence of biochemical abnormalities related to kidney disease, compared with similar patients who started GLP-1 receptor agonist treatment.